Related Experiment Video
Updated: May 19, 2026

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
Published on: December 1, 2017
ATG16L1 and pathogenesis of urinary tract infections
Caihong Wang1, Jane W Symington, Indira U Mysorekar
1Department of Obstetrics and Gynecology, Washington University School of Medicine St. Louis, St. Louis, MO, USA.
Abstract:
Autophagy is generally considered to be antipathogenic. The autophagy gene ATG16L1 has a commonly occurring mutation associated with Crohn disease (CD) and intestinal cell abnormalities. Mice hypomorphic for ATG16L1 (ATG16L1(HM)) recreate specific features of CD. Our recent study shows that the same ATG16L1(HM) mice that are susceptible to intestinal inflammatory disease are protected from urinary tract infections (UTI), a common and important human disease primarily caused by uropathogenic E. coli (UPEC). UPEC colonize the bladder and exhibit both luminal and intra-epithelial stages. The host responds by recruiting innate immune cells and shedding infected epithelial cells to clear infection. Despite these countermeasures, UPEC can persist within the bladder epithelium as membrane-enclosed quiescent intracellular reservoirs (QIRs) that can seed recurrent UTI. The mechanisms of persistence remain unknown. In this study, we show that ATG16L1 deficiency protects the host against acute UTI and UPEC latency. ATG16L1(HM) mice clear urinary bacterial loads more rapidly and thoroughly due to ATG16L1-deficient innate immune components. Furthermore, ATG16L1(HM) mice exhibit superficial urothelial cell-autonomous architectural aberrations that also result in significantly reduced QIR numbers. Our findings reveal a host-protective effect of ATG16L1 deficiency in vivo against a common pathogen.
Insights
ATG16L1 deficiency protects against urinary tract infections (UTIs) by enhancing bacterial clearance and reducing pathogen reservoirs. This finding reveals a novel host-protective role for ATG16L1 in combating uropathogenic E. coli (UPEC).
Area of Science:
- Microbiology
- Immunology
- Cell Biology
Background:
- Autophagy is generally considered antipathogenic, but the role of the autophagy gene ATG16L1 in host defense against bacterial infections is complex.
- Mutations in ATG16L1 are linked to Crohn disease (CD), and mice with reduced ATG16L1 function (ATG16L1(HM)) model CD features.
- Intriguingly, ATG16L1(HM) mice, susceptible to intestinal inflammation, show protection against urinary tract infections (UTIs).
Purpose of the Study:
- To investigate the role of ATG16L1 deficiency in host protection against acute urinary tract infections (UTIs) and uropathogenic E. coli (UPEC) persistence.
- To elucidate the mechanisms by which ATG16L1 deficiency impacts UPEC colonization, innate immune response, and the formation of quiescent intracellular reservoirs (QIRs).
Main Methods:
- Utilized ATG16L1 hypomorphic (ATG16L1(HM)) mice to study UPEC infection models.
- Assessed bacterial loads, innate immune cell recruitment, and urothelial cell morphology in infected mice.
- Quantified the formation of quiescent intracellular reservoirs (QIRs) within the bladder epithelium.
Main Results:
- ATG16L1(HM) mice demonstrated accelerated and more complete clearance of UPEC from the urinary tract.
- ATG16L1 deficiency in innate immune components contributed to enhanced bacterial clearance.
- Urothelial cells in ATG16L1(HM) mice exhibited architectural aberrations, leading to a significant reduction in UPEC QIR formation.
Conclusions:
- ATG16L1 deficiency confers protection against acute UTI and UPEC latency.
- The protective effect is mediated by both enhanced innate immune responses and altered urothelial cell architecture.
- This study reveals a novel host-protective role for ATG16L1 deficiency against common bacterial pathogens like UPEC.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction
Microbiota of the Urogenital Tract
Acute Kidney Injury II: Pathophysiology
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Acute Pyelonephritis I: Introduction

